Healthcare provider profile · identity verified

Daniel C Huber, M.D.

Family Practice · VERGENNES, VT · NPI 1164491221

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	320	83
Lisinopril	Lisinopril	250	70
Levothyroxine Sodium	Levothyroxine Sodium	227	51
Gabapentin	Gabapentin	202	58
Omeprazole	Omeprazole	183	55
Amlodipine Besylate	Amlodipine Besylate	171	50
Metoprolol Succinate	Metoprolol Succinate	157	46
Losartan Potassium	Losartan Potassium	154	45
Rosuvastatin Calcium	Rosuvastatin Calcium	148	40
Tamsulosin Hcl	Tamsulosin Hcl	147	43
Eliquis	Apixaban	146	34
Simvastatin	Simvastatin	141	41
Metformin Hcl	Metformin Hcl	118	33
Ozempic	Semaglutide	113	20
Hydrochlorothiazide	Hydrochlorothiazide	109	34
Metformin Hcl Er	Metformin Hcl	95	28
Pantoprazole Sodium	Pantoprazole Sodium	91	23
Mounjaro	Tirzepatide	82	16
Sertraline Hcl	Sertraline Hcl	80	25
Albuterol Sulfate Hfa	Albuterol Sulfate	76	28
Furosemide	Furosemide	76	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	13
Citalopram Hbr	Citalopram Hydrobromide	69	23
Hydroxyzine Hcl	Hydroxyzine Hcl	66	13
Oxycodone Hcl	Oxycodone Hcl	66	15
Trazodone Hcl	Trazodone Hcl	65	21
Allopurinol	Allopurinol	63	18
Prednisone	Prednisone	63	31
Carvedilol	Carvedilol	62	14
Famotidine	Famotidine	62	22
Glipizide Er	Glipizide	55	20
Duloxetine Hcl	Duloxetine Hcl	54	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	54	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	53	11
Jardiance	Empagliflozin	51	19
Metoprolol Tartrate	Metoprolol Tartrate	50	17
Zolpidem Tartrate	Zolpidem Tartrate	49	14
Lorazepam	Lorazepam	48	24
Meloxicam	Meloxicam	46	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	15
Bupropion Xl	Bupropion Hcl	41	12
Ezetimibe	Ezetimibe	41	13
Cephalexin	Cephalexin	36	28
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Spironolactone	Spironolactone	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	11
Promethazine Hcl	Promethazine Hcl	29	suppressed
Baclofen	Baclofen	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Atenolol	Atenolol	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	24
Donepezil Hcl	Donepezil Hcl	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Finasteride	Finasteride	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	18
Terazosin Hcl	Terazosin Hcl	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Glipizide	Glipizide	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Chlorthalidone	Chlorthalidone	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Torsemide	Torsemide	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Temazepam	Temazepam	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Lansoprazole	Lansoprazole	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	11
Celecoxib	Celecoxib	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Novofine 32	Pen Needle, Diabetic	13	suppressed
Nystatin	Nystatin	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Ssd	Silver Sulfadiazine	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Azithromycin	Azithromycin	11	11
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error